Healthium MedTech Supports GIMS In Delivering Advanced Paediatric Orthopaedic Surgeries

IMT News Desk
IMT News Desk
· 2 min read
Healthium MedTech’s CSR support helps GIMS, Greater Noida deliver advanced paediatric orthopaedic surgeries for children

The Government Institute of Medical Sciences (GIMS), Greater Noida, with support from Healthium MedTech’s CSR initiative and implemented by Plan International India Chapter, is now fully equipped to undertake advanced paediatric orthopaedic surgeries.

In a major boost to child healthcare, the institute can now treat conditions such as developmental dysplasia of the hip (DDH), clubfoot, limb deformities, fractures and complex bone disorders. With the installation of specialised equipment including the Midas Rex MR8 High Speed Electric Drill System, Paediatric Hip Plating Set, Paediatric and Small Bone Drill & Saw System, Paediatric Orthopaedic Instrument Set and a C-Arm Machine, GIMS is now ready to deliver precise, safe and age-appropriate surgical care for children.

Speaking at the launch, the Chief Guest, Dr. G.N. Singh, Adviser to the Hon’ble Chief Minister, Uttar Pradesh said, This initiative reflects our commitment to ensuring that every child, regardless of background, has access to quality and timely healthcare. Strengthening public health institutions through such partnerships is essential to building an inclusive and equitable healthcare system.”

Dr. (Brig.) Rakesh Kumar Gupta, Director General, GIMS, emphasised the institution’s enhanced capability, stating, “With this advanced equipment, GIMS is now prepared to handle complex paediatric orthopaedic cases with greater precision and safety. This will significantly reduce referrals and ensure that children receive timely treatment closer to home.”

Highlighting the organisation’s commitment to strengthening healthcare access, Anish Bafna, CEO & MD, Healthium Medtech, said, “At Healthium, we are focused on improving clinical outcomes by enabling both innovation and access. Supporting initiatives such as the GIMS and Plan International India Chapter project reflects our effort to strengthen care delivery systems and equip healthcare providers with the tools needed to deliver specialised paediatric orthopaedic care. By enhancing on-ground capabilities, we aim to ensure that timely, reliable treatment reaches children who need it the most.”

Shri Mohammed Asif, Executive Director, Plan International (India Chapter), said, Through this partnership, we are strengthening access to specialised paediatric healthcare for vulnerable communities. This intervention will directly benefit over 1,000 children every year, ensuring they receive timely, safe and life-changing orthopaedic treatment without financial or geographic barriers.”

With this initiative, GIMS is emerging as a critical centre for paediatric orthopaedic care in western Uttar Pradesh, ensuring that children can access advanced treatment, regain mobility, and lead healthier, more independent lives.

Read Next

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya
News
June 5, 2026

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya

Union Health Minister J P Nadda on Thursday declared that the Central Government remains firmly committed to strengthening healthcare infrastructure across the Northeast and ensuring that advanced medical services reach people living in remote and underserved areas of the region. Nadda made these remarks while inaugurating ARHI Hospital in Meghalaya’s Ri-Bhoi district- a new super-specialty […]
Article by: IMT News Desk
Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today
News
June 5, 2026

Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today

Mumbai-based Hexagon Nutrition Ltd has mobilised Rs 41.66 crore from anchor investors ahead of its initial public offering (IPO), which opened for public subscription on June 5 and will remain open until June 9, 2026. According to a circular uploaded on BSE’s website, the company allotted a total of 92.57 lakh equity shares to anchor […]
Article by: IMT News Desk
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
News
June 5, 2026

Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval

Otsuka Pharmaceutical has reported that its approved kidney disease drug Voyxact (sibeprenlimab) preserved kidney function over 12 months in a late-stage clinical study, marking a significant milestone in the treatment of immunoglobulin A nephropathy (IgAN), a serious autoimmune condition that progressively damages the kidneys. In the Phase 3 VISIONARY trial involving 320 participants, patients who […]
Article by: IMT News Desk
Akums Receives European CEP Approval for Cefpodoxime Proxetil
News
June 4, 2026

Akums Receives European CEP Approval for Cefpodoxime Proxetil

Akums Drugs & Pharmaceuticals Ltd. has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its active pharmaceutical ingredient (API), Cefpodoxime Proxetil. The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the requirements of the European Pharmacopoeia. The […]
Article by: IMT News Desk